Shukra Pharmaceuticals Limited (BOM:524632)
India · Delayed Price · Currency is INR 55.87
+0.14 (0.25%)
At close: Sep 25, 2026
Shukra Pharmaceuticals Market Cap
Shukra Pharmaceuticals has a market cap or net worth of 24.56 billion as of September 25, 2026. Its market cap has increased by 69.20% in one year.
Market Cap
24.56B
Enterprise Value
24.55B
Revenue
748.59M
Ranking
n/a
PE Ratio
69.12
Stock Price
55.87
ChartMarket Cap Chart
Since February 23, 2012, Shukra Pharmaceuticals's market cap has increased from 46.16M to 24.56B, an increase of 53,107.61%. That is a compound annual growth rate of 53.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 24.56B | -5.33% |
| Dec 31, 2025 | 25.94B | 334.48% |
| Dec 31, 2024 | 5.97B | 340.79% |
| Dec 29, 2023 | 1.35B | 554.74% |
| Dec 30, 2022 | 206.90M | 58.55% |
| Dec 30, 2021 | 130.50M | 105.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Gufic Biosciences | 42.41B |
| Unichem Laboratories | 38.74B |
| Kwality Pharmaceuticals | 38.10B |
| Hikal | 26.87B |
| Fredun Pharmaceuticals | 22.51B |
| Venus Remedies | 22.32B |
| Syncom Formulations (India) | 18.86B |
| Amrutanjan Health Care | 14.63B |